Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?
This is a quality of life study measuring subjective improvement as well as objective response to estimate the benefit of palliative chemotherapy in women with platinum resistant or refractory ovarian cancer.Click here for more information OVAR16 A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy versus Placebo in Women who have not progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancers.